Rationale and clinical data supporting nutritional intervention in Alzheimer’s disease

References

• Reddy PH. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer’s disease. Brain Res. 2011;1415:136–48.
   PubMed Web of Science ®Google Scholar
• DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol. 1990;27:457–64.
   PubMed Web of Science ®Google Scholar
• Terry RD. Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol. 2000;59:1118–9.
   PubMed Web of Science ®Google Scholar
• de Wilde MC, Kamphuis PJ, Sijben JW, Scheltens P. Utility of imaging for nutritional intervention studies in Alzheimer’s disease. Eur J Pharmacol. 2011;668 Suppl 1: S59–69.
   Web of Science ®Google Scholar
• Mosconi L, McHugh PF. FDG- and amyloid-PET in Alzheimer’s disease: is the whole greater than the sum of the parts? Q J Nucl Med Mol Imaging. 2011;55:250–64.
   PubMed Web of Science ®Google Scholar
• Grantham-McGregor S. Chronic undernutrition and cognitive abilities. Hum Nutr Clin Nutr. 1984;38:83–94.
   PubMedGoogle Scholar
• Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009;66:216–25.
   PubMed Web of Science ®Google Scholar
• Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol. 2006;59:912–21.
   PubMed Web of Science ®Google Scholar
• Phillips MA, Childs CE, Calder PC, Rogers PJ. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer’s disease. Nutr Neurosci. 2012. [Epub ahead of print].
   Google Scholar
• van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, . Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology. 2008;71:430–8.
   PubMed Web of Science ®Google Scholar
• Dangour AD, Allen E, Elbourne D, Fasey N, Fletcher AE, Hardy P, . Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr. 2010;91:1725–32.
   PubMed Web of Science ®Google Scholar
• Geleijnse JM, Giltay EJ, Kromhout D. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement. 2012;8:278–87.
   PubMed Web of Science ®Google Scholar
• Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, . Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010;6:456–64.
   PubMed Web of Science ®Google Scholar
• Lee LK, Shahar S, Chin AV, Yusoff NA. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2013;225:605–12.
   PubMed Web of Science ®Google Scholar
• Rondanelli M, Opizzi A, Faliva M, Mozzoni M, Antoniello N, Cazzola R, . Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment. Nutr Neurosci. 2012;15:46–54.
   PubMed Web of Science ®Google Scholar
• Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J, . Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr. 2012;107:1682–93.
   PubMed Web of Science ®Google Scholar
• Stough C, Downey L, Silber B, Lloyd J, Kure C, Wesnes K, . The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population. Neurobiol Aging. 2012;33:824 e1–3.
   PubMedGoogle Scholar
• Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, . Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304:1903–11.
   PubMed Web of Science ®Google Scholar
• Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, . The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1538–44.
   PubMed Web of Science ®Google Scholar
• Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, . Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63:1402–8.
   PubMed Web of Science ®Google Scholar
• Eussen SJ, de Groot LC, Joosten LW, Bloo RJ, Clarke R, Ueland PM, . Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr. 2006;84:361–70.
   PubMed Web of Science ®Google Scholar
• Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, . Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 2007;369:208–16.
   PubMed Web of Science ®Google Scholar
• Ford AH, Flicker L, Alfonso H, Thomas J, Clarnette R, Martins R, . Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology. 2010;75:1540–7.
   PubMed Web of Science ®Google Scholar
• Walker JG, Batterham PJ, Mackinnon AJ, Jorm AF, Hickie I, Fenech M, . Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms–the Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr. 2012;95:194–203.
   PubMed Web of Science ®Google Scholar
• Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, . Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010;5:e12244.
   PubMed Web of Science ®Google Scholar
• Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, . Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379–88.
   PubMed Web of Science ®Google Scholar
• Kang JH, Cook N, Manson J, Buring JE, Grodstein F. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med. 2006;166:2462–8.
   PubMed Web of Science ®Google Scholar
• Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, . Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures. Arch Neurol. 2012;69:836–41.
   PubMed Web of Science ®Google Scholar
• van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9:112–24.
   PubMed Web of Science ®Google Scholar
• Titova OE, Sjogren P, Brooks SJ, Kullberg J, Ax E, Kilander L, . Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly. Age (Dordr). 2013;35:1495–505.
   PubMed Web of Science ®Google Scholar
• Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, . A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci. 2005;25:3032–40.
   PubMed Web of Science ®Google Scholar
• Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012;6:CD005379.
   PubMed Web of Science ®Google Scholar
• Danthiir V, Burns NR, Nettelbeck T, Wilson C, Wittert G. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. Nutr J. 2011;10:117.
   PubMed Web of Science ®Google Scholar
• Wurtman RJ, Cansev M, Ulus IH. Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides. J Nutr Health Aging. 2009;13:189–97.
   PubMed Web of Science ®Google Scholar
• Czech C, Berndt P, Busch K, Schmitz O, Wiemer J, Most V, . Metabolite profiling of Alzheimer’s disease cerebrospinal fluid. PLoS One. 2012;7:e31501.
   PubMed Web of Science ®Google Scholar
• Richter Y, Herzog Y, Eyal I, Cohen T. Cognitex supplementation in elderly adults with memory complaints: an uncontrolled open label trial. J Diet Suppl. 2011;8:158–68.
   PubMedGoogle Scholar
• Smith AD. The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr Bull. 2008;29:S143–72.
   PubMed Web of Science ®Google Scholar
• Sachdev PS, Valenzuela M, Wang XL, Looi JC, Brodaty H. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology. 2002;58:1539–41.
   PubMed Web of Science ®Google Scholar
• Kado DM, Karlamangla AS, Huang MH, Troen A, Rowe JW, Selhub J, . Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med. 2005;118:161–7.
   PubMed Web of Science ®Google Scholar
• Morris MS, Selhub J, Jacques PF. Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the framingham heart study. J Am Geriatr Soc. 2012;60:1457–64.
   PubMed Web of Science ®Google Scholar
• Vauzour D. Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev. 2012;2012:914273.
   PubMed Web of Science ®Google Scholar
• Wurtman RJ, Cansev M, Sakamoto T, Ulus IH. Use of phosphatide precursors to promote synaptogenesis. Annu Rev Nutr. 2009;29:59–87.
   PubMed Web of Science ®Google Scholar
• Cansev M, Watkins CJ, van der Beek EM, Wurtman RJ. Oral uridine-5'-monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Res. 2005;1058:101–8.
   PubMed Web of Science ®Google Scholar
• van Wijk N, Watkins CJ, Böhlke M, Maher TJ, Hageman RJ, Kamphuis PJ, . Plasma choline concentration varies with different dietary levels of vitamins B6, B12 and folic acid in rats maintained on choline-adequate diets. Br J Nutr. 2012;107:1408–12.
   PubMed Web of Science ®Google Scholar
• van Wijk N, Watkins CJ, Hageman RJ, Sijben JC, Kamphuis PG, Wurtman RJ, . Combined dietary folate, vitamin B-12, and vitamin B-6 intake influences plasma docosahexaenoic acid concentration in rats. Nutr Metab (Lond). 2012;9:49.
   PubMedGoogle Scholar
• Cansev M, Wurtman RJ. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience. 2007;148:421–31.
   PubMed Web of Science ®Google Scholar
• Cansev M, Marzloff G, Sakamoto T, Ulus IH, Wurtman RJ. Giving uridine and/or docosahexaenoic acid orally to rat dams during gestation and nursing increases synaptic elements in brains of weanling pups. Dev Neurosci. 2009;31:181–92.
   PubMed Web of Science ®Google Scholar
• Cansev M, Ulus IH, Wang L, Maher TJ, Wurtman RJ. Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson’s disease. Neurosci Res. 2008;62:206–9.
   PubMed Web of Science ®Google Scholar
• Holguin S, Huang Y, Liu J, Wurtman R. Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats. Behav Brain Res. 2008;191:11–6.
   PubMed Web of Science ®Google Scholar
• Holguin S, Martinez J, Chow C, Wurtman R. Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J. 2008;22:3938–46.
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Cansev M, Wurtman RJ. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 2007;1182:50–9.
   PubMed Web of Science ®Google Scholar
• Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 2006;1088:83–92.
   PubMed Web of Science ®Google Scholar
• Shrivastava R, Vincent B, Gobron S, Cucuat N, John GW. Evidence for growth-promoting effects of omega n-3 fatty acids alone and in combination with a specific vitamin and mineral complex in rat neuroblastoma cells. Nutr Neurosci. 2005;8:317–21.
   PubMed Web of Science ®Google Scholar
• Arellano JI, Espinosa A, Fairen A, Yuste R, DeFelipe J. Non-synaptic dendritic spines in neocortex. Neuroscience. 2007;145:464–9.
   PubMed Web of Science ®Google Scholar
• de Wilde MC, Penke B, van der Beek EM, Kuipers AA, Kamphuis PJ, Broersen LM. Neuroprotective effects of a specific multi-nutrient intervention against Abeta42-induced toxicity in rats. J Alzheimers Dis. 2011;27:327–39.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Hossain S, Agdul H, Shido O. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta. 2005;1738:91–8.
   PubMed Web of Science ®Google Scholar
• Arendash GW, Jensen MT, Salem N Jr, Hussein N, Cracchiolo J, Dickson A, . A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer’s transgenic mice. Neuroscience. 2007;149:286–302.
   PubMed Web of Science ®Google Scholar
• de Wilde MC, Farkas E, Gerrits M, Kiliaan AJ, Luiten PG. The effect of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion. Brain Res. 2002;947:166–73.
   PubMed Web of Science ®Google Scholar
• de Wilde MC, Hogyes E, Kiliaan AJ, Farkas T, Luiten PG, Farkas E. Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive rats. Brain Res. 2003;988:9–19.
   PubMed Web of Science ®Google Scholar
• Broersen LM, Kuipers AA, Balvers M, van Wijk N, Savelkoul PJ, de Wilde MC, . A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AbetaPPswe/PS1dE9 mice. J Alzheimers Dis. 2013;33:177–90.
   PubMed Web of Science ®Google Scholar
• Harris E, Macpherson H, Vitetta L, Kirk J, Sali A, Pipingas A. Effects of a multivitamin, mineral and herbal supplement on cognition and blood biomarkers in older men: a randomised, placebo-controlled trial. Hum Psychopharmacol. 2012;27:370–7.
   PubMed Web of Science ®Google Scholar
• Wolters M, Hickstein M, Flintermann A, Tewes U, Hahn A. Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation. Prev Med. 2005;41:253–9.
   PubMed Web of Science ®Google Scholar
• McNeill G, Avenell A, Campbell MK, Cook JA, Hannaford PC, Kilonzo MM, . Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial. Nutr J. 2007;6:10.
   PubMed Web of Science ®Google Scholar
• Andreeva VA, Kesse-Guyot E, Barberger-Gateau P, Fezeu L, Hercberg S, Galan P. Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. Am J Clin Nutr. 2011;94:278–86.
   PubMed Web of Science ®Google Scholar
• Kesse-Guyot E, Fezeu L, Jeandel C, Ferry M, Andreeva V, Amieva H, . French adults’ cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. Am J Clin Nutr. 2011;94:892–9.
   PubMed Web of Science ®Google Scholar
• Scheltens P, Kamphuis PJ, Verhey FR, Olde Rikkert MG, Wurtman RJ, Wilkinson D, . Efficacy of a medical food in mild Alzheimer’s disease: A randomized, controlled trial. Alzheimers Dement. 2010;6:1–10e1.
   PubMed Web of Science ®Google Scholar
• Scheltens P, Twisk JW, Blesa R, Scarpini E, von Arnim CA, Bongers A, . Efficacy of Souvenaid in mild Alzheimer’s disease: results from a randomized, controlled trial. J Alzheimers Dis. 2012;31:225–36.
   PubMed Web of Science ®Google Scholar
• Siegel M, Donner TH, Engel AK. Spectral fingerprints of large-scale neuronal interactions. Nat Rev Neurosci. 2012;13:121–34.
   PubMed Web of Science ®Google Scholar
• Shah R, Kamphuis P, Leurgans S, Swinkels S, Sadowsky C, Bongers A, Rappaport S, Quinn J, Wieggers R, Bennett D, Scheltens P. Souvenaid® as an add-on intervention in patients with mild to moderate Alzheimer’s disease using Alzheimer’s disease medication: results from a randomized, controlled, double-blind study (S-Connect). CtAD, San Diego, November 2011; J Nutr Health Aging 2011;15 (Suppl 1) S30 (Abstract P38).
   Google Scholar